The role of recombinant factor VIIa in liver transplantation
β Scribed by Robert J. Porte; Stephen H. Caldwell
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 55 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20447
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Patients undergoing orthotopic liver transplantation (OLT) have excessive blood loss during surgery that requires blood transfusions, leading to increased postoperative morbidity and mortality. We studied the efficacy and safety of activated recombinant factor VII (rFVIIa) in reducing transfusio
Orthotopic liver transplantation (OLT) can be associated with excessive blood loss. As a result, there may be increased risk of adverse outcomes. Activated recombinant factor VII (rFVIIa) has demonstrated the ability to improve hemostasis in a variety of disorders; however, there has been a limited
## Abstract ## Background: ABOβincompatible (ABOβi) liver transplantation (LT) is a highβrisk procedure due to the potential for antibodyβmediated rejection (AMR) and cellβmediated rejection. The aim of the current report is to illustrate the results of a retrospective comparison study on the use